In the AD brains, TPI is oxidized by carbonyl and nitrotyrosinated modification, disrupting its enzymatic activity. Nitrotyrosinated TPI interacts with Tau to promote intraneuronal aggregation and increases methylglyoxal toxic proteins. Here, MAPT is linked to Alzheimer disease.